Pharmaceutical Management: Our Impact

Photo: From left: Johnnie Amenyah of JSI, Gladys Tetteh, Francis Aboagye-Nyame, Dinah Tjipura, and Kwesi Eghan of the SIAPS Program attending the End-of-Program event on March 1, 2018 in Arlington, VA. (Santita Ngo/MSH) On Thursday, March 1, 2018, MSH held an end-of-program event for the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) program.

{Photo Credit: Liza Talukder}Jahidul Hasan works on the adverse drug event report.Photo Credit: Liza Talukder

The Directorate General of Drug Administration (DGDA)—with technical assistance from the USAID-funded SIAPS program, implemented by MSH—officially launched Bangladesh’s national pharmacovigilance (PV) program in 2013. After being first introduced at 20 private and public hospitals, and 13 pharmaceutical companies, the DGDA and SIAPS have organized trainings for focal persons to build their skills and knowledge on PV and increase adverse drug event (ADE) reporting.

{Photo Credit: Wezi Tjaronda}Olavi Shomongula shares his testimony with U.S. Ambassador to Namibia Thomas F. Daughton.Photo Credit: Wezi Tjaronda

A new electronic health tool developed by the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) program, implemented byMSH, is being used in more than 50 public health facilities in Namibia. This tool—the Facility Electronic Stock Card (FESC)—has noticeably expedited the dispensing of medication to patients. This was evident when the US Ambassador to Namibia H.E. Thomas F. Daughton visited the Intermediate Hospital Oshakati (IHO), which is in the populous Oshana region in the North-Central part of Namibia.

{Photo Credit: Henry Nyaka}Grace Mathunda.Photo Credit: Henry Nyaka

At the time that Grace Mathunda started to fall ill, she also grew increasingly concerned over the poor health of her second child. Eventually he became so weak that he stopped going to school. When Mathunda, 32, became pregnant again, she went to Makhetha Health Center in Blantyre, Malawi, where she was tested for HIV. As with over 30 percent of people living with HIV in the country, Mathunda was unaware of her status.[1] She tested positive.

{Photo Credit: UNICEF SYRIA/ ALEPPO, 2016/AL-ISSA.}After years of ongoing conflict, Syrian children face the prospect of a ravaged health system.Photo Credit: UNICEF SYRIA/ ALEPPO, 2016/AL-ISSA.

Management Sciences for Health (MSH) is helping countries in the Middle East and WHO Eastern Mediterranean region design, finance, and deliver health service packages toward universal health coverage (UHC). Two MSH representatives, David Collins and David Lee, attended a meeting in Cairo recently to discuss the way forward. They presented ideas on health service packages for countries in crisis and how these are necessary to help countries transition from humanitarian health services to long-term, sustainable health systems.

Health extension worker Lemlem Worku gives Zara Ahmed amoxicillin antibiotics for her 10 month old baby.Photo credit: UNICEF Ethiopia / CC BY-NC-ND

Devex has reported on the role of well-trained health workers in the fight against antimicrobial resistance (AMR). Increasing levels of AMR — a result of the misuse of drugs, poor-quality medication and improper prescriptions, among other factors — is a threat not only to people’s health, but also to the global economy, poverty levels, and the achievement of the Sustainable Development Goals.

A technician tests a child for malaria at a health center in Kinshasa, DRC.Photo Credit: Aubrey Clark

The USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program, led by MSH, recently published the results of its activities in eight countries (Angola, Burundi, the Democratic Republic of the Congo (DRC), Ethiopia, Kenya, Guinea, Mali, and South Sudan) to control malaria.

{Photo Credit: Tadeo Atuhura/MSH}Photo Credit: Tadeo Atuhura/MSH

How US Foreign Assistance is Making A Difference Uganda has made great progress in controlling the HIV epidemic and increasing access to critical HIV and health services in recent years. Under the Government of Uganda’s leadership and with the support of development partners, such as MSH, Uganda has reached the second of UNAIDS global 90-90-90 goals: 90% of people living with HIV who know their status are on treatment. 

 {Photo credit: Wezi Tjaronda (MSH/SIAPS Namibia)}Pharmacist in charge of the Facility Electronic Stock Card (FESC) at Oshakati Hospital, Tesema Zelalem (seated) shows the US Ambassador to Namibia, Thomas Daughton (right) and Senior Pharmacist of the hospital, Mesele Walellign a print out of available medicines in the pharmacy, from the FESC computer on July 13, 2017.Photo credit: Wezi Tjaronda (MSH/SIAPS Namibia)

The U.S. Ambassador to Namibia, H.E. Thomas Daughton, visited a hospital and clinic in the Oshana region of Namibia last week to unveil a new electronic stock card, an innovation that has greatly improved service delivery in the country.

 {Photo credit: SIAPS Namibia}ART Pharmacy in Oshikuku District Hospital, Omusati Region, Namibia.Photo credit: SIAPS Namibia

In a major advance against the spread of HIV, Namibia has approved the use of emtricitabine/tenofovir disoproxil fumarate (TDF/FTC) to prevent HIV infection. The Namibian Medicines Regulatory Council (NMRC) approved a generic version of the medicine, Ricovir EM®, which is manufactured by Mylan Pharmaceuticals. It is used in combination with other antiretroviral medications to treat AIDS. When taken daily, it can reduce the risk of sexually transmitted HIV by more than 90%. To date, very few African countries have approved the regimen for use as pre-exposure prophylaxis, or PrEP.

Pages

Printer Friendly Version